Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$926K Buy
8,157
+45
+0.6% +$5.35K 0.1% 77
2024
Q2
$1M Buy
8,112
+1,750
+28% +$225K 0.12% 69
2024
Q1
$839K Buy
6,362
+98
+2% +$12.1K 0.12% 52
2023
Q4
$683K Buy
6,264
+157
+3% +$16.3K 0.15% 56
2023
Q3
$629K Buy
6,107
+365
+6% +$39.3K 0.16% 54
2023
Q2
$663K Sell
5,742
-6
-0.1% -$681 0.17% 54
2023
Q1
$612K Buy
5,748
+19
+0.3% +$2.05K 0.22% 58
2022
Q4
$636K Buy
5,729
+2,078
+57% +$212K 0.25% 60
2022
Q3
$314K Hold
3,651
0.16% 83
2022
Q2
$333K Sell
3,651
-136
-4% -$12.1K 0.14% 72
2022
Q1
$311K Buy
3,787
+64
+2% +$5.05K 0.13% 86
2021
Q4
$285K Buy
3,723
+5
+0.1% +$398 0.12% 90
2021
Q3
$279K Buy
3,718
+14
+0.4% +$1.06K 0.15% 85
2021
Q2
$288K Sell
3,704
-161
-4% -$12K 0.16% 82
2021
Q1
$284K Buy
3,865
+29
+0.8% +$2.14K 0.22% 74
2020
Q4
$304K Buy
+3,836
New +$293K 0.26% 68

Other funds holding MRK

Diversified's MRK Position: Q3 2024 in Review

Diversified increased its Merck (MRK) stake by 0.55% in Q3 2024, buying an estimated $5.35K and bringing the position to 8,157 shares worth $926K. The position accounts for 0.1% of the portfolio, ranked #77.

Diversified first reported a position in MRK in Q4 2020 and has held it in 16 quarters since. The position peaked at $1M in Q2 2024. 3,491 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Diversified held 8,157 shares of Merck worth $926K as of Q3 2024.
  • Diversified bought 45 Merck shares in Q3 2024, an estimated $5.35K.
  • Merck made up 0.1% of Diversified's portfolio in Q3 2024, its #77 holding.
  • Diversified first reported a position in Merck in Q4 2020 and has held it in 16 quarters since.
  • Diversified's Merck position peaked at $1M in Q2 2024.
  • 3,491 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Diversified's 13F filing for Q3 2024, filed 13 Nov 2024.